id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1222637,e17fec05-b3ce-4b41-8ecc-bb82627cbd65,Q1,"RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)",400361684,"VIJUK EQUIPMENT, INC.",2012,first_quarter,MED,any issue relating to pharmaceutical labeling,,25000,,0,0,2012-03-30T10:49:56.770000-04:00
1222691,8b9cb3b0-199e-49de-a24f-ac185760a0b2,Q1,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2012,first_quarter,MED,"FY 2011 Appropriations                                                      Residency Caps
FY 2012 Appropriations                                                      Minority Improvement
Medical Affordability Act                                                   False Claims Correction Act
Research Misconduct Clinical Trials                                 NIOSH Education and Research Centers for Occupational Health and Safety Pathways for Biosimilars Act
Prevention Research Centers
Resident Physician Shortage
Health Care Reform","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)",,88684,0,0,2012-04-02T10:31:37.897000-04:00
1222715,02096854-f368-4afe-a8ff-fef756770e01,Q1,MARSHALL BRACHMAN,6848,BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM,2012,first_quarter,MED,support funding for medical research programs,"HOUSE OF REPRESENTATIVES,SENATE",33000,,0,0,2012-04-02T10:48:47.033000-04:00
1222953,b4da78dc-63b8-4f68-b921-ebbd79788d02,Q1,GRIZZLE COMPANY,16987,UNIVERSITY OF LOUISVILLE,2012,first_quarter,MED,Request support for NIH grant application,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-04-02T16:16:53.483000-04:00
1223552,4667272d-6d6f-47a3-bc46-ad13a7a18604,Q1,HEALY STRATEGIES,311495,UNIVERSITY OF MARYLAND MEDICAL SYSTEM,2012,first_quarter,MED,"The Prescription Drug User Fee Act (PDUFA), drug shortages",SENATE,,,0,0,2012-04-05T10:36:32.170000-04:00
1224052,1a8f0256-c349-4254-9e04-cc00e5a53e3b,Q1,WAKE FOREST UNIVERSITY HEALTH SCIENCES,6781,WAKE FOREST UNIVERSITY HEALTH SCIENCES,2012,first_quarter,MED,"NIH Budget including Title VII & VIII programs
VA-Outpatient Clinic in N.C.(RFP-land acquisition)","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",,160000,0,0,2012-04-09T10:43:32.813000-04:00
1224155,9f4a4a6b-fcd4-4180-9ae4-c0ade8f96421,Q1,ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC),1466,ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC),2012,first_quarter,MED,"AACC wrote to House Energy and Commerce leaders raising concerns regarding the impact of H.R.3207, the Modernizing Laboratory Test Standards for Patients Act of 2011, on patient access to laboratory developed tests, test innovation, the ability of of differing health care providers to be able to conduct LDTs, and the potential regulatory costs associated with adopting the bill.","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-04-09T14:13:40.077000-04:00
1224196,9aaa2329-37bc-479b-aaff-b14a0000efe6,Q1,THE HARRIS FIRM,68376,DIRECT MESSAGE LAB,2012,first_quarter,MED,Regarding funding pertaining to software communication system for chronic disease management.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-04-09T15:11:05.097000-04:00
1224616,a644b84d-2092-40b1-ad3f-6c2d828472ea,Q1,LATHAM & WATKINS LLP,22201,BOSTON SCIENTIFIC CORPORATION,2012,first_quarter,MED,Congressional oversight of the Food and Drug Administration.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-04-10T16:13:30.707000-04:00
1224929,64b5a2ef-9c82-476d-a6a4-944a186f598f,Q1,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2012,first_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and  Medicare Part D plans.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,61700,0,0,2012-04-11T11:31:16.407000-04:00
1225080,6ccf28a6-af12-44f0-816f-a43df84b26f1,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"BRAIDWOOD MANAGEMENT, INC.",2012,first_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.   No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-04-11T14:35:38.287000-04:00
1225090,49e4e169-62c5-4c82-85b4-f76ce34d1f62,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,DIAMONDBACK DRUGS,2012,first_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.   No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",6000,,0,0,2012-04-11T14:47:43.123000-04:00
1225105,e1cecf85-bc63-45f6-993c-a69b93598b21,Q1,"THE PETRIZZO GROUP, INC.",305932,FRED HUTCHINSON CANCER RESEARCH CENTER,2012,first_quarter,MED,"Advocated for funding for the National Institutes of Health and National Cancer Institute for FY 2013 funding
Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases 
Advocated for support of House Dear Colleague Letter asking for signatures for additional NIH Funding Opposed H.R. 3699, which prohibits a federal agency from adopting, maintaining, continuing, or otherwise engaging in any policy, program, or other activity that: (1)causes, permits, or authorizes network dissemination of any private-sector research work without the prior consent of the publisher; or (2) requires that any actual or prospective author, or the author's employer, assent to such network dissemination. 

Organized Fred Hutchinson Cancer Research Center (FHCRC) event demonstrating the importance of the work FHCRC is doing in Washington State and the region","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-04-11T15:10:52.077000-04:00
1225109,05fb58da-d0d3-402d-bc76-db5c4d9fab98,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"VETERINARY PHARMACIES OF AMERICA, INC.",2012,first_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-04-11T15:11:54.920000-04:00
1225142,9b0d85c7-824e-42d4-8368-023a48f021d7,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WEDGEWOOD VILLAGE PHARMACY, INC.",2012,first_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-04-11T15:40:17.113000-04:00
1225150,d7ddb76b-e396-4a4b-9476-e413f0eb9bf0,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WOMEN'S INTERNATIONAL PHARMACY, INC.",2012,first_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-04-11T15:52:23.123000-04:00
1225349,3f1be42a-a024-4eba-a734-ce8813a073e4,Q1,"THE PETRIZZO GROUP, INC.",305932,MVP SERVICE CORP.,2012,first_quarter,MED,"Advocated concerns with negative consequences of the Patient Protection and Affordable Care Act (ACA), specifically 1) new taxes that will cause premium increases and rais cost of health care coverage; 2) cuts to Medicare Advantage funding; 3) weak individual mandate resulting in adverse selection; and 4) HHS proposed regulation that omits fraud and abuse prevention, concurrent review and costs associated with the federally-mandated ICD-10 program from health care quality improvement programs.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-04-12T09:15:15.540000-04:00
1225548,e02b0cd6-3b22-4508-8206-b281afa183fe,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,AIDS HEALTHCARE FOUNDATION,2012,first_quarter,MED,"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 - Support funding for medical treatment for HIV positive patients.  Support appropriate funding for the ADAP program.  Continue appropriate funding for Chronic Care Special Needs clinics under Medicare.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-12T12:30:27.190000-04:00
1225803,c4f98656-0d89-4d15-a88d-64fa11ed9a84,Q1,"DALRYMPLE & ASSOCIATES, LLC",5073,DISCOVERY LABORATORIES,2012,first_quarter,MED,"Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight.","Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",16000,,0,0,2012-04-12T15:19:47.033000-04:00
1225831,94d984ab-b0a2-416c-a538-4cb6f7753a35,Q1,"DALRYMPLE & ASSOCIATES, LLC",5073,EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION),2012,first_quarter,MED,"Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.","Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",46000,,0,0,2012-04-12T15:32:57.997000-04:00
1225842,07ede6f6-8c29-4e62-8f41-c94e8af8d045,Q1,"DALRYMPLE & ASSOCIATES, LLC",5073,SANOFI PASTEUR,2012,first_quarter,MED,"Vaccine research and development legislation, funding, appropriations and oversight.","Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office",46000,,0,0,2012-04-12T15:38:01.903000-04:00
1225858,5c5566ba-f547-442e-aab8-d2a40e925338,Q1,CHARLIE MCBRIDE ASSOCIATES,24214,BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA,2012,first_quarter,MED,To monitor legislation affecting medical energy research and technology-based economic development,"HOUSE OF REPRESENTATIVES,SENATE",7200,,0,0,2012-04-12T15:39:04.963000-04:00
1225994,49a1f40e-ae39-4b2d-94ed-6bdcbf56009d,Q1,BEN BARNES GROUP LP,5415,HUNTSMAN CANCER INSTITUTE,2012,first_quarter,MED,Medical Research Funding,"HOUSE OF REPRESENTATIVES,SENATE",75000,,0,0,2012-04-12T20:43:30.363000-04:00
1225997,76ea4abf-00a8-4cc2-ad33-13a850a9caf1,Q1,BEN BARNES GROUP LP,5415,OKLAHOMA RESEARCH MEDICAL FOUNDATION,2012,first_quarter,MED,Medical Research Funding,"HOUSE OF REPRESENTATIVES,SENATE",20100,,0,0,2012-04-12T21:00:32.700000-04:00
1226070,e3b9698f-b159-4923-bdeb-9e5aa7d1fb0c,Q1,DENNY MILLER ASSOCIATES,25328,CELL THERAPEUTICS,2012,first_quarter,MED,"FDA appeal process for new drug applications.  Prescription Drug and User Fee Act Reauthorization (no number), provisions relating to approval of new drugs.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-13T10:03:25.597000-04:00
1226155,b9c30fc5-6b2b-4ad3-a06d-be136bf7af2e,Q1,PALMETTO GROUP,18570,INTERNATIONAL AIDS VACCINE INITIATIVE,2012,first_quarter,MED,"Federal Funding of AIDS vaccine
S.1601 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2012",SENATE,42000,,0,0,2012-04-13T10:21:58.797000-04:00
1226210,0567497e-004f-4c0d-8e58-07c65433172b,Q1,DENNY MILLER ASSOCIATES,25328,STB CORPORATION,2012,first_quarter,MED,Issues pertaining to the fiscal 2012 Defense appropriations bill (P.L. 112-74) and defense health program funding.,HOUSE OF REPRESENTATIVES,,,0,0,2012-04-13T10:32:18.647000-04:00
1226436,e59d68d1-1521-42c7-ad90-f06f1dfa35cf,Q1,ASSOCIATION OF UNIVERSITY CENTERS ON DISABLITIES,1728,ASSOCIATION OF UNIVERSITY CENTERS ON DISABLITIES,2012,first_quarter,MED,Intellectual and developmental disabilities research within the NIH,"Administration for Children & Families (ACF),Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE",,40000,0,0,2012-04-13T12:21:46.057000-04:00
1226551,db3b0c01-8bab-4d49-a621-cad06dfca651,Q1,"DEPARTMENT FOR PROFESSIONAL EMPLOYEES, AFL-CIO",12094,DEPARTMENT FOR PROFESSIONAL EMPLOYEES AFL-CIO,2012,first_quarter,MED,Antibiotics research and development.,"Commerce, Dept of (DOC),Executive Office of the President (EOP),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE,State, Dept of (DOS),Treasury, Dept of",,,0,0,2012-04-13T14:15:53.130000-04:00
1226568,908559be-f3c9-4e70-86ef-1dbb2d91917a,Q1,"KSCW, INC.",21596,INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS (IAMERS,2012,first_quarter,MED,Legislation and regulation affecting the Medical device industry,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-04-13T14:19:04.003000-04:00
1226718,0071c9a7-458b-42d0-9d83-7f9f138b4639,Q1,ASSN OF MEDICAL DEVICE REPROCESSORS,291732,ASSN OF MEDICAL DEVICE REPROCESSORS,2012,first_quarter,MED,"Educated Congressional staff, members of Congress, and other agency officials on the FDA-regulated, third-party reprocessing industry and ongoing efforts to implement similar regulations internationally. Initiated discussions on upcoming MDUFA reauthorization.","Commerce, Dept of (DOC),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,U.S. International Trade Commission (ITC)",,20000,0,0,2012-04-13T15:38:06.860000-04:00
1227021,257d43c3-1268-49a0-8c24-cd60a4b1f767,Q1,BEN BARNES GROUP LP,5415,TEXAS A&M SYSTEM,2012,first_quarter,MED,"Assist the Texas A&M System in pursuit of various research projects, general government relations","Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2012-04-13T19:03:53.217000-04:00
1227154,7fdeec34-072b-48d8-9d7f-82264107f3f9,Q1,"FRANCIS EDWARD & CRONIN, INC.",311314,CURE ALZHEIMER'S FUND,2012,first_quarter,MED,Legislation and issues related to Alzheimer's Disease Research,"Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl AIDS Policy,Office of Science & Technology Policy (OSTP),SENATE,White House Office",10000,,0,0,2012-04-14T19:20:48.820000-04:00
1227551,501b3f05-1fd8-458e-9afd-cc1c7ad02e41,Q1,"THE CJR GROUP, INC.",288293,STERIS CORPORATION,2012,first_quarter,MED,Biomedical issues,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-04-16T11:13:32.547000-04:00
1227566,20e58f83-d596-4fcd-8a39-7c479546486a,Q1,"THE CJR GROUP, INC.",288293,UNIVERSITY HOSPITALS HEALTH SYSTEM,2012,first_quarter,MED,Medical issues relating to hospitals,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-04-16T11:17:39.907000-04:00
1227616,5b2c39e0-e357-4676-92f2-5abf75b5ab8b,Q1,"THE PETRIZZO GROUP, INC.",305932,"SAGE THERAPEUTICS, INC.",2012,first_quarter,MED,Letter of Support for Innovation Grant Application,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-16T11:29:03.333000-04:00
1227643,5d875db2-0dbc-4fd8-8fdc-a515379e54cf,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL ASSOCIATION OF EPILEPSY CENTERS,2012,first_quarter,MED,Research and public health programs in epilepsy.,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,0,2012-04-16T11:42:16.477000-04:00
1227863,d2ab3b88-45df-4418-a9c3-c797a2e25587,Q1,AMERICAN ASSOCIATION FOR CANCER RESEARCH,400601833,AMERICAN ASSOCIATION FOR CANCER RESEARCH,2012,first_quarter,MED,drug shortage,"HOUSE OF REPRESENTATIVES,SENATE",,25000,0,0,2012-04-16T13:00:58.913000-04:00
1227883,c9bd38de-87f6-41f7-867d-2ae233e2bdfc,Q1,"MEHLMAN CONSULTING, INC.",284950,NATIONAL VENTURE CAPITAL ASSOCIATION,2012,first_quarter,MED,"FDA reform:  Changes to PDUFA (Prescription Drug User Fee Act) and MDUFA (Medical Device User Fee Act) programs.
H.R. 4132, Faster Access to Specialized Treatments (FAST) Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act; H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011; S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012","Executive Office of the President (EOP),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of",60000,,0,0,2012-04-16T13:06:09.617000-04:00
1227908,c9cc548e-2c69-4add-a243-572b710386e6,1A,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL ASSOCIATION OF EPILEPSY CENTERS,2012,first_quarter,MED,Research and public health programs in epilepsy.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,0,2012-04-16T13:14:23.227000-04:00
1227981,e78c4805-ba10-4012-bc77-6f2616a84829,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,STATE UNIVERSITY SYSTEM OF FLORIDA,2012,first_quarter,MED,Appropriations and Authorization legislation for FY 2013 in health care,"Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE",70000,,0,0,2012-04-16T13:51:58.323000-04:00
1227994,ae9ba712-f51c-47fc-b4f5-d7faa15597d0,Q1,PARALYZED VETERANS OF AMERICA,30724,PARALYZED VETERANS OF AMERICA,2012,first_quarter,MED,"Department of Veterans Affairs, Medical Research Issues
National Institutes of Health, Medical Research Issues","HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)",,92927,0,0,2012-04-16T13:54:01.277000-04:00
1228049,72592ccf-07b5-4361-8c49-3e42b5b5fa18,Q1,"THE PETRIZZO GROUP, INC.",305932,SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION,2012,first_quarter,MED,Advocated for legislation to create pediatric research hubs to maximize the impact of existing pediatric research capacity and boost funding for research benefitting children.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-16T14:08:23.547000-04:00
1228058,3533108b-4144-4e89-8908-72988d9de630,Q1,THOMPSON HINE LLP,38051,TEXAS BIOMEDICAL RESEARCH INSTITUTE,2012,first_quarter,MED,"Legislative and regulatory matters regarding the use of chimpanzees in biomedical research (i.e., the Great Ape Protection and Cost Savings Act and possible ""endangered species"" designation for chimpanzees by the U.S. Fish and Wildlife Service).","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-04-16T14:11:26.377000-04:00
1228102,dd56ff6f-8f88-4164-a1af-62d4292b1f23,Q1,POLICY DIRECTIONS INC.,31747,BAYLOR COLLEGE OF MEDICINE,2012,first_quarter,MED,"S. 606  and HR 3059- Creating Hope Act of 2011 - issues related to neglected tropical disease research and treatment.
HR 528 - Neglected Infections of Impoverished Americans Act of 2011.
House & Senate Farm Bill (No Bill), Research Title","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-16T14:20:40.643000-04:00
1228155,7f9f0a66-6fe6-45f8-8e55-03b3ea30421c,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL HEMOPHILIA FOUNDATION,2012,first_quarter,MED,"Hemophilia research, prevention, surveillance and service programs and issues. HR1919 Bleeding Disorders Screening Awareness and Further Education Act of 2011","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",50000,,0,0,2012-04-16T14:48:02.390000-04:00
1228275,eb8f33e3-2e40-4f9a-a9be-d07c7fa61943,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ASSOCIATION OF AMERICA'S BLOOD BANKS,2012,first_quarter,MED,"Blood safety and management issues.  HHS Advisory Committee on Blood Safety and Availability. 
Research related to Biovigilance.","Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-04-16T15:28:54.543000-04:00
1228320,10b6347b-c0d0-42a1-96a5-1656f01c1fc9,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,AMERICAN SOCIETY OF HEMATOLOGY,2012,first_quarter,MED,Research in hematology.,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2012-04-16T15:44:13.423000-04:00
1228340,9b523eaf-fc2d-4a7d-9829-71a40388b56e,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TUBEROUS SCLEROSIS ALLIANCE,2012,first_quarter,MED,"No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, Tuberous Sclerosis
No Bill #, Defense Appropriations, FY 2013
Defense health programs, Tuberous Sclerosis Complex Research Program","Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2012-04-16T15:50:22.067000-04:00
1228446,a1c80ccf-b945-4b65-a040-94110532e153,Q1,SANOFI US SERVICES INC.,56838,SANOFI US SERVICES INC,2012,first_quarter,MED,Reauthorization of the Prescription Drug User Fee Act (PDUFA),"HOUSE OF REPRESENTATIVES,SENATE",,750000,0,0,2012-04-16T16:42:19.697000-04:00
1228974,920e94be-5bf2-4678-b141-b39090e5ad6b,Q1,"MEHLMAN CONSULTING, INC.",284950,AMERICAN CLINICAL LABORATORY ASSOCIATION,2012,first_quarter,MED,"Health reform law implementation issues including application of medical device tax to clinical laboratory tests and laboratory fee schedule.      In-office ancillary services exception to Stark Law.
H.R. 3207, The Modernizing Laboratory Test Standards for Patients Act.
H.R. 3630, The Middle Class Tax Relief and Job Creation Act of 2012 (Became PL 112-96 on 2/22/12).","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",60000,,0,0,2012-04-17T09:51:04.570000-04:00
1229363,61de16d6-97f9-41e6-8ffa-a4fa23873e3c,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,"SAGE PUBLICATIONS, INC.",2012,first_quarter,MED,"HR4004, S.2096, Federal Research Public Access Act; National Institutes of Health Open Access policy
No Bill#, America COMPETES Act, implementation of public access policy at federal science agencies
No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, NIH Open Access Policy, Department of Education Title II Funding
HR3699, Research Works Act No Bill#, Reauthorization of Elementary and Secondary Education Act, Title II Funding","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-17T12:40:12.147000-04:00
1229375,8b5656fd-d806-4566-a300-798aef767ee7,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION,2012,first_quarter,MED,"No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research
No Bill #, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease
HR 640, Bone Marrow Failure Disease Research and Treatment Act","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2012-04-17T12:43:18.383000-04:00
1229386,46db7999-a353-46d6-914c-a808d390cc2f,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ASSOCIATION FOR MOLECULAR PATHOLOGY,2012,first_quarter,MED,"Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 1249, America Invents Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act","Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE",30000,,0,0,2012-04-17T12:48:24.853000-04:00
1229425,00d8e56b-fe54-463b-af69-1912654e05e2,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,INTERNATIONAL MYELOMA FOUNDATION,2012,first_quarter,MED,HR 2746 Cancer Drug Coverage Parity Act; HR 2245/S.296 Preserving Access to Lifesaving Medications Act,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-04-17T13:08:40.263000-04:00
1229429,2db75f22-fb21-418f-8e2d-515eaa20363a,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ONYX PHARMACEUTICALS,2012,first_quarter,MED,"Innovation in biotechnology; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases, health disparities, drug shortages.  HR 4132 Faster Access to Specialized Treatments (FAST) Act; S.2113 Transforming the Regulatory Environment to Accellerate Access to Treatments (TREAT) Act; HR 2245/S.296: Preserving Access to Lifesaving Medications Act;   
No Bill #: Prescription Drug User Fee Act reauthorization","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2012-04-17T13:10:42.267000-04:00
1229433,91b48e7c-12c9-426e-9529-242db3cbc019,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TETHYS BIOSCIENCE,2012,first_quarter,MED,"Regulation and reimbursement of laboratory developed tests.
No Bill #: BETTER Patient Care Act","Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-17T13:13:45.063000-04:00
1229626,023d15e9-eef8-4259-8d4b-a37281ed2e86,Q1,"MEHLMAN CONSULTING, INC.",284950,MAYO CLINIC,2012,first_quarter,MED,"NIH appropriations
Clinical laboratory reimbursement","Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-04-17T14:34:10.613000-04:00
1229723,ead71cc1-a354-4af7-959a-82d0f7949bca,Q1,SRI INTERNATIONAL,90990,SRI INTERNATIONAL,2012,first_quarter,MED,"Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 (HR 2405)
FY13 House and Senate Labor/HHS/Education Appropriations","HOUSE OF REPRESENTATIVES,SENATE",,90000,0,0,2012-04-17T14:59:44.323000-04:00
1229733,d9ea4f47-ae6e-4020-93c7-808835767a42,Q1,OGR,48827,ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED),2012,first_quarter,MED,Medical Device User Fee Act and related issues,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-17T15:00:46.697000-04:00
1229891,b8651b0c-65d7-428c-9cec-531462294f7f,Q1,WASHINGTON UNIVERSITY IN ST. LOUIS,40031264,WASHINGTON UNIVERSITY IN ST LOUIS,2012,first_quarter,MED,"General advocacy for NIH research, genomics research, and improved conflict of interest policies.  Advocacy in support of clear, productive federal stem cell research guidelines","HOUSE OF REPRESENTATIVES,SENATE",,40000,0,0,2012-04-17T15:55:17.783000-04:00
1229951,3577e297-a41b-4986-9b72-5ca56bea34cd,Q1,"THE NORMANDY GROUP, LLC",306636,"CENTER FOR DISEASE DETECTION, LLC",2012,first_quarter,MED,"Seek assistance from Dept. of Commerce, Dept. of State in effort to expand medical testing in Latin America.","Commerce, Dept of (DOC),Job Corps,State, Dept of (DOS)",30000,,0,0,2012-04-17T16:07:19.910000-04:00
1230135,e820c22a-f43b-4fd8-a3ad-8e60f00fe5d1,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ),2012,first_quarter,MED,General discussions regarding the rauthorization of the Prescription Drug User Fee Act (PDUFA); and education and awareness of vaccine production and infrastructure needs.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-17T16:46:36.223000-04:00
1230201,f70986f6-57ad-48ff-b02e-5462cfb7e71f,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE,2012,first_quarter,MED,Public Health Programs for Infectious and Tropical Disease; CDC Infection and Vector Borne Disease  and Global Health Programs; Department of Defense Tropical Medicine Research; National Institutes of Health Tropical Medicine Programs.,"Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-17T17:02:07.133000-04:00
1230206,8207daac-6afc-4625-b8a3-ea8c699b3d7e,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,"CHILDREN'S CARDIOMYOPATHY FOUNDATION, INC.",2012,first_quarter,MED,"H.R. 3625/S.2124 - The Cardiomyopathy Health, Education, Awareness, Risk Assessment, and Training in the Schools Act;  Development of a Registry on Sudden Cardiac Arrest.","Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2012-04-17T17:04:10.527000-04:00
1230236,08a8e589-e7bb-4dd3-b206-dad763618b9c,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA,2012,first_quarter,MED,Public Health and Medical Research Programs for Neglected and Infectious and Pediatric HIV/AIDS Diseases; H.R. 528 - Neglected Infections of Impoverished Americans Act; S. 606 - Creating Hope Act of 2011.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-04-17T17:09:25.623000-04:00
1230300,9a08f9f7-483b-4764-af41-819acc203ac7,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,NATIONAL PSORIASIS FOUNDATION,2012,first_quarter,MED,"H.R. 2033/S.1107 - Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011; Psoriasis Data Collection.","Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2012-04-17T17:28:53.143000-04:00
1230346,73330b26-d538-43a1-966b-a0d7fefd9a4f,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,OVARIAN CANCER NATIONAL ALLIANCE,2012,first_quarter,MED,Ovarian Cancer Research and Awareness; Implementation of Johanna's Law.,"Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-04-17T17:41:12.713000-04:00
1230370,1f68f71f-890c-43b2-8271-92c0cdeac6ae,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,PREECLAMPSIA FOUNDATION,2012,first_quarter,MED,"FY 2013 Labor, Health and Human Services, and Education Appropriations Bill - Preeclampsia Research Issues; National Health Calendar","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",10000,,0,0,2012-04-17T17:50:24.120000-04:00
1230392,047df64a-1565-4f80-97e6-c2283e2caa4b,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,PREVENT BLINDNESS,2012,first_quarter,MED,Eye Disease and Vision Health; Treatment and Prevention of Blindness and Vision Loss.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-04-17T17:52:31.077000-04:00
1230412,99ddaf5d-854c-4ed1-ac38-66c5da52a913,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,RIVERAIN MEDICAL,2012,first_quarter,MED,Increasing awareness of lung cancer and making it a public health priority,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-17T17:57:38.153000-04:00
1230419,f1ca1478-ad54-493e-bdbb-e305173df83c,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,SPINA BIFIDA ASSOCIATION,2012,first_quarter,MED,Spina Bifida Research and Awareness and Access to Care; Folic Acid Fortification.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-17T17:58:39.860000-04:00
1230460,3cfc9d3c-d966-4da2-86b0-befe2b6c8024,Q1,OGR,48827,CONSUMER HEALTHCARE PRODUCTS ASSOCIATION,2012,first_quarter,MED,Issues related to insuring access to over-the-counter drugs.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-04-17T18:46:56.503000-04:00
1230790,a2ea0e8a-e51c-4c6e-8570-c8143cd7d571,Q1,SQUIRE PATTON BOGGS,30906,"MELA SCIENCES, INC.",2012,first_quarter,MED,FDA regulatory procedures with respect to melanoma detection systems.,Food & Drug Administration (FDA),10000,,0,0,2012-04-18T06:48:58.157000-04:00
1231383,ea9f36d3-c180-48d2-9e0f-7e5ed019edba,Q1,GOLDBUG STRATEGIES LLC,400701094,COALITION FOR 21ST CENTURY MEDICINE,2012,first_quarter,MED,"FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
HR 3207","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2012-04-18T11:05:00.567000-04:00
1231416,1def08d1-2ee3-4c34-b07b-e93f08786563,Q1,GOLDBUG STRATEGIES LLC,400701094,GENOMIC HEALTH INC.,2012,first_quarter,MED,"FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Tricare payment of laboratory developed tests.
HR 3207","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-04-18T11:11:14.740000-04:00
1231610,585919ec-d229-48c0-b23e-51b5c462365b,Q1,TURNER & GOSS LLP,316310,CYSTIC FIBROSIS FOUNDATION,2012,first_quarter,MED,"Legislation reauthorizing the Prescription Drug User Fee Act
S.2281/HR 4156, Expanding and Promoting Expertise in Review of Rare Treatments Act","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-04-18T11:38:40.420000-04:00
1231769,e56cd330-a490-4914-9d07-d778f9fbf61b,Q1,"TCH GROUP, LLC",51478,SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ),2012,first_quarter,MED,General discussion regarding the reauthorization of the Prescription Drug User Fee Act (PDUFA),"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-04-18T11:56:50.163000-04:00
1231989,02217219-07c7-4bac-8917-534994e125b7,1T,"NATIONAL GROUP, LLP",66090,PROVIDENCE HEALTH SYSTEM,2012,first_quarter,MED,Medical research and equipment funding,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2012-04-18T12:28:22.270000-04:00
1232034,63d882fc-c83d-4e82-9ff8-dbaa7abbdff7,Q1,"FEDERAL SOLUTIONS, LLC",311371,JACKSONVILLE STATE UNIVERSITY,2012,first_quarter,MED,"Labor/HHS/Education Appropriations Bill 2012:  Provisions relating to disease research, education, and development","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-04-18T12:40:40.507000-04:00
1232052,9f4194c1-6029-4836-abff-ebc4fd8612a6,Q1,"FEDERAL SOLUTIONS, LLC",311371,MISSISSIPPI STATE UNIVERSITY,2012,first_quarter,MED,"Labor/HHS/Education Appropriations Bill, 2012: Provisions relating to disease research","Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Aeronautics & Space Administration (NASA),Natl Oceanic & Atmospheric Administration (NOAA),SENATE",50000,,0,0,2012-04-18T12:44:47.760000-04:00
1232133,8d8f219e-4adf-4477-8c65-2e8181b7afa2,Q1,"HARRISON RIVARD DUNCAN & BUZZETT, CHTD.",72257,HCA HEALTHCARE,2012,first_quarter,MED,Health and Medical Issues,,,,0,0,2012-04-18T12:59:15.187000-04:00
1232377,6e03b9b2-aa99-46db-82a9-f85f9c567e40,Q1,FAEGRE BAKER DANIELS CONSULTING,34158,COUNCIL FOR AMERICAN MEDICAL INNOVATION (CAMI),2012,first_quarter,MED,"Funding of the FDA & NIH, Regulatory System at the FDA","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-04-18T13:50:12.690000-04:00
1232598,1758b03e-847e-49d9-abde-9caeb2f3b6e6,Q1,"W STRATEGIES, LLC",400605842,"23ANDME, INC.",2012,first_quarter,MED,"Issues relating to regulation of Direct to Consumer Genetic Testing and education and outreach regarding genetic testing and personalized medicine. 
H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011.
Issues related to genetics and Parkinsons' Disease","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-18T14:15:52.570000-04:00
1232613,58b8ff40-f7c4-4442-918c-ea777e162ca4,Q1,FOLEY & LARDNER LLP,15042,"FLUGEN, INC.",2012,first_quarter,MED,Funding for vaccine research and development and vaccine delivery product.,"Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-04-18T14:17:57.527000-04:00
1232628,4eed60ba-ab96-49cf-a9fb-d66216fa8833,Q1,"GRAY & OSCAR, LLC (FORMERLY BOB GRAY, LLC)",33124,IMX MEDICAL MANAGEMENT SERVICES,2012,first_quarter,MED,"Informed Members of the Pennsylvania Congressional Delegation regarding IMX's efforts to receive consideration of their medical evaluation services with the Department of Veterans Affairs, Department of Defense, and the Department of Labor.","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE",,,0,0,2012-04-18T14:19:02.967000-04:00
1232714,7151b6cc-03c1-423d-b407-dbd6695259bf,Q1,FOLEY & LARDNER LLP,15042,PHOENIX NUCLEAR LABS LLC,2012,first_quarter,MED,Legislation to promote development of radio-isotopes for medical diagnostics and therapy,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-04-18T14:27:40.423000-04:00
1232759,1c455f67-fe03-44d4-9427-ceade82780c7,Q1,DIALYSIS PATIENT CITIZENS,400460287,DIALYSIS PATIENT CITIZENS,2012,first_quarter,MED,"Importance of anemia management for ESRD patients
Prioritizing patient role in infection prevention efforts at dialysis facilities","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA),White House Office",,75000,0,0,2012-04-18T14:32:00.627000-04:00
1232844,cf337e7c-d908-4c16-9723-d08d9571aec2,Q1,FAEGRE BAKER DANIELS CONSULTING,34158,ARTHRITIS FOUNDATION,2012,first_quarter,MED,"NIH Research, CDC Public Health, Medicare, Children's Health","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-04-18T14:41:44.693000-04:00
1232923,9411533f-61d0-452d-a0b6-a33ce5f2da6c,Q1,"WHITMER & WORRALL, LLC",292892,NEURO KINETICS,2012,first_quarter,MED,Issues related to Traumatic Brain Injury (TBI).,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-04-18T14:50:21.367000-04:00
1232992,2f1fb43b-56c7-413d-9a6e-1a420f5a84ae,Q1,FAEGRE BAKER DANIELS CONSULTING,34158,COALITION FOR EXCELLENCE IN MEDICATION MONITORING,2012,first_quarter,MED,Medicare & Medicaid Coverage & Payment,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-18T14:56:48.167000-04:00
1233120,e13f4626-97ff-40b2-a3d4-51620d451260,Q1,FIRST STRATEGIC,91091,TRANSLATIONAL GENOMICS RESEARCH INSTITUTE,2012,first_quarter,MED,The Creating Hope Act - issues regarding drug development for pediatric rare diseases.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-04-18T15:13:41.250000-04:00
1233156,9ff4055a-6184-4311-a470-cbaaf54dc563,Q1,PRIME POLICY GROUP,400532589,"VERAX BIOMEDICAL, INC.",2012,first_quarter,MED,Blood Safety,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-18T15:17:56.907000-04:00
1233223,827c890e-8d4e-4263-9bc7-a133875a529d,Q1,FIRST STRATEGIC,91091,PHOENIX CHILDREN'S HOSPITAL,2012,first_quarter,MED,"Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. Creation of the saftey net care pool through CMS.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-04-18T15:26:30.800000-04:00
1233239,6becab38-2fee-4784-afd5-f5c3bda6213d,Q1,FAEGRE BAKER DANIELS CONSULTING,34158,LEARNING & EDUCATION ACADEMIC RESEARCH NETWORK,2012,first_quarter,MED,National Institute of Child Health & Human DevelopmentResearch Grants,"Education, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE",20000,,0,0,2012-04-18T15:27:35.300000-04:00
1233329,7a7c607d-030b-433f-a005-345bbbdf8763,Q1,PHOENIX CHILDREN'S HOSPITAL,400381743,PHOENIX CHILDREN'S HOSPITAL,2012,first_quarter,MED,"Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. Creation of the saftey net care pool through CMS.","HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2012-04-18T15:38:12.447000-04:00
1233639,0a9323c6-1506-4d6a-9f50-35931616d38a,1T,ASSOCIATION OF AMERICAN UNIVERSITIES,40048368,ASSOCIATION OF AMERICAN UNIVERSITIES,2012,first_quarter,MED,TBD  NIH Funding  appropriations and effect on higher education institutions,"HOUSE OF REPRESENTATIVES,SENATE",,28661,0,1,2012-04-18T16:29:21.557000-04:00
1233719,d08b5782-ddb9-49a5-a2b1-338e0c9ee55b,Q1,VENABLE LLP,39941,AMPHASTAR PHARMACEUTICALS INC.,2012,first_quarter,MED,Primatene Mist Sunset Date,"Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-04-18T16:42:04.953000-04:00
1233785,3c5f571e-269e-4985-b056-e82d3122e731,Q1,"ELECTROCHEMICAL OXYGEN CONCEPTS, INC. DBA EO2 CONCEPTS",400804407,"ELECTROCHEMICAL OXYGEN CONCEPTS, INC. DBA EO2 CONCEPTS",2012,first_quarter,MED,No lobbying activity.,"HOUSE OF REPRESENTATIVES,SENATE",,60000,0,0,2012-04-18T16:56:50.223000-04:00
1233884,26738e9f-241e-4686-b0c0-9690bc1d91cd,Q1,INFECTIOUS DISEASES SOCIETY OF AMERICA,54836,INFECTIOUS DISEASES SOCIETY OF AMERICA,2012,first_quarter,MED,Medical liability; antimicrobial resistance research; infectious diseases product research and development; regulatory science; unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; support for evidence-based decision making; and point-of-care diagnostic tests.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Agency for International Development (USAID)",,103264,0,0,2012-04-18T17:22:50.410000-04:00